Skyhawk Therapeutics
ID: 5330850Skyhawk Therapeutics is a RNA-correcting Small Molecules founded in 2016 by Bill Haney.
2
Funding Rounds
$48.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Bi** Ha*** |
|
- | |
| Ka****** Mc****** |
|
- |
Funding series
Funding Series Analysis
The company Skyhawk Therapeutics has raised a total of $48m in funding over 2 rounds.
Key Insights:
- Skyhawk Therapeutics , June 2018: $40m
- Skyhawk Therapeutics Seed round, January 2018: $8m
Industries
Skyhawk Therapeutics is active in the following industries: